(Q47373704)

15 January 2018

title

IP-10-encoding plasmid DNA therapy exhibits anti-tumor and anti-metastatic efficiency (English)

1 reference

15 January 2018

author

Kristin Ladell

3

1 reference

15 January 2018

author name string

Johanna Keyser

1

1 reference

15 January 2018

Jan Schultz

2

1 reference

15 January 2018

Lina Elzaouk

4

1 reference

15 January 2018

Lucie Heinzerling

5

1 reference

15 January 2018

Jovan Pavlovic

6

1 reference

15 January 2018

Karin Moelling

7

1 reference

15 January 2018

publication date

1 June 2004

1 reference

15 January 2018

published in

Experimental Dermatology

1 reference

15 January 2018

volume

13

1 reference

15 January 2018

issue

6

1 reference

15 January 2018

page(s)

380-390

1 reference

15 January 2018

Immune responses to DNA vaccines

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Update on antiviral DNA vaccine research (1998-2000).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Intra-pinna anti-tumor vaccination with self-replicating infectious RNA or with DNA encoding a model tumor antigen and a cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1beta converting enzyme cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Long-lasting anti-metastatic efficiency of interleukin 12-encoding plasmid DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Intratracheal administration of interleukin 12 plasmid-cationic lipid complexes inhibits murine lung metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): a novel, pleiotropic member of the C-X-C chemokine superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Cancer vaccines based on the identification of genes encoding cancer regression antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

New paths in human cancer serology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Immune surveillance against a solid tumor fails because of immunological ignorance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer models

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

Immunology. Licence to kill

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

The central role of CD4(+) T cells in the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0906-6705.2004.00191.X

10.1111/J.0906-6705.2004.00191.X

21 January 2018

Identifiers

DOI

1 reference

15 January 2018

1 reference

15 January 2018